Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Histologic Type × niraparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Neoplasms 6 Breast Neoplasms 6 Fallopian Tube Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 2 Neoplasm Metastasis 2 Esophageal Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Stomach Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Adenocarcinoma 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroblastoma 1 Metastatic Castration-sensitive Prostate Cancer 1 Mesothelioma 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

ponatinib 4 Rituximab 3 Gemcitabine 3 130-nm albumin-bound paclitaxel 3 pralsetinib 2 pembrolizumab 2 napabucasin 2 Vincristine 2 Prednisone 2 Irinotecan 2 Imatinib Mesylate 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Brentuximab Vedotin 2 tetulomab tetraxetan lu-177 1 ricolinostat 1 pomalidomide 1 pamiparib 1 nirogacestat 1 nilotinib 1 ibritumomab tiuxetan 1 denileukin diftitox 1 bosutinib 1 blinatumomab 1 Vorinostat 1 Temozolomide 1 Radiation 1 Pemetrexed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡